Compound information
- Natural Products
- ZC2673235
- Molecular Formula
- C21H21F3N4O3
- Molecular Weight
- 434.156575192 g/mol
- Structure
-
- IUPAC Name
- [4-(cyclopropylamino)-3-nitro-phenyl]-[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]methanone
- InChI
- InChI=1S/C21H21F3N4O3/c22-21(23,24)15-2-1-3-17(13-15)26-8-10-27(11-9-26)20(29)14-4-7-18(25-16-5-6-16)19(12-14)28(30)31/h1-4,7,12-13,16,25H,5-6,8-11H2
- InChI Key
- JGMLQHBVDYLFRB-UHFFFAOYSA-N
- SMILES
- O=C(c1ccc(NC2CC2)c([N+](=O)[O-])c1)N1CCN(c2cccc(C(F)(F)F)c2)CC1
- Source
- ZINC000025965185
Warheads
- Cyclopropane
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 31 | Ring Count | 4 |
Heteroatom Count | 10 | Rotatable Bond Count | 5 |
Hydrogen Bond Acceptor Count | 5 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 78.72 Å2 | LogP | 4.001 |
LogS | -4.922 | LogD | 3.745 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.967 | Pgp substrate | 0.995 |
HIA | 0.967 | F20 % | 0.989 |
F30 % | 0.981 | Caco-2 | -4.989 |
MDCK | -5.157 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.016 | PPB | 97.151 |
VD | 2.399 | Fu | 1.608 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.015 | CYP1A2 substrate | 0.7 |
CYP2A6 substrate | 0.556 | CYP2B6 substrate | 0.585 |
CYP2C19 inhibitor | 0.865 | CYP2C19 substrate | 0.892 |
CYP2C8 substrate | 0.604 | CYP2C9 inhibitor | 0.899 |
CYP2C9 substrate | 0.271 | CYP2D6 inhibitor | 0.326 |
CYP2D6 substrate | 0.918 | CYP2E1 substrate | 0.249 |
CYP3A4 inhibitor | 0.805 | CYP3A4 substrate | 0.999 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.071 | CL | 1.332 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.794 | Hepatotoxicity | 0.987 |
Mutagenicity | 0.828 | Rat Oral Acute Toxicity | 0.713 |
FDAMDD | 0.843 | Skin Sensitization | 0.993 |
Carcinogenicity | 0.153 | Eye Corrosion | 0.001 |
Eye Irritation | 0.041 | Respiratory Toxicity | 0.951 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.464 | IGC50 | 3.554 |
LC50FM | -10.831 | LC50DM | -2.854 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.756 | NR-AR-LBD | 0.358 |
NR-AhR | 0.7 | NR-Aromatase | 0.395 |
NR-ER | 0.61 | NR-ER-LBD | 0.672 |
NR-PPAR-gamma | 0.491 | SR-ARE | 0.847 |
SR-ATAD5 | 0.588 | SR-HSE | 0.755 |
SR-MMP | 0.639 | SR-p53 | 0.776 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.